Can neurostimulation really help dry eye patients?
9 monthes ago - By Healio
TrueTear, officially launched just months ago at the American Society of Cataract and Refractive Surgery meeting, is the first-ever neurostimulation device in eye care, offering a drug-free, drop-free option to temporarily increase tear production during neurostimulation in adult patients. It has become an important addition to our armamentarium at our Dry Eye Center of Excellence. TrueTear provides small pulses to stimulate production of patients' own natural tears. It is Bluetooth enabled and features a connected application, making it the first “smart” device in eye care.
Read more ...
The headlines of Master Doctor
9/11 Dust, First Responders' Prostate Cancers Linked?
Exposure to dust at the New York City site after the terrorist attacks triggered chronic inflammation in the responders' prostates, which may have contributed to their cancer...
Can Diet Treat Chronic Pain?
Whether it's the aches and pain of osteoarthritis, chronic back pain, or an old sports injury, many people fight a battle with chronic pain. According to the Centers for...
Vagus nerve stimulation may reduce the symptoms of rheumatoid arthritis
A new study suggests that electrostimulation of the vagus nerve may reduce the symptoms of rheumatoid arthritis and other chronic inflammatory conditions.
MRI Plus Systematic Sampling Ups First-Time Prostate-Biopsy Hits
In biopsy-naive men, combining MRI with systematic sampling of the imaged lesions increases detection of clinically significant prostate cancer, according to California-based...
Zimmer Biomet announces new chief financial officer
Zimmer Biomet Holdings Inc. recently announced that Suketu “Suky” Upadhyay has been appointed to executive vice president and chief financial officer of the company as Daniel...
Scientists discover new drug target for chemically induced Parkinson's disease
More than three decades ago, scientists discovered that a chemical found in a synthetic opioid, MPTP, induced the onset of a form of Parkinson's disease.
Hypertension treatment may slow down Alzheimer's progression
New research finds that nilvadipine, a drug doctors commonly use to treat high blood pressure, increases the blood flow to the brain's hippocampus.
Comparing RT Schedules in Prostate Ca
Ultra-hypofractionation vs conventional approach for intermediate-risk disease
Elderly Women With Osteoporosis: to Treat or Not to Treat?
Mortality, fracture risk much more probable in osteoporosis